Key facts
- This page summarizes Patrick Machado's Form 3 filing for Turnstone Biologics Corp. (TSBX).
- 0 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 20 Jul 2023, 21:52.
Patrick Machado - 20 Jul 2023 Form 3 Insider Report for Turnstone Biologics Corp. (TSBX)
- Reporting relationship
- Director
- Issuer ticker
- TSBX
- Reported as of
- 20 Jul 2023
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 20 Jul 2023, 21:52:00 UTC
- Prior SEC filing
- 16 Jun 2023
- Next SEC filing
- 06 Oct 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ P. Joseph Campisi, Jr., Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Patrick Machado filed Form 3 for Turnstone Biologics Corp. (TSBX) on 20 Jul 2023.
Change
- Previous filing in this sequence was filed on 16 Jun 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TSBX
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 20 Jul 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 20,383
- Exercise price
- $2.87
- Footnotes
- F1
TSBX
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 20 Jul 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 18,870
- Exercise price
- $10.30
- Footnotes
- F2
TSBX
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 20 Jul 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 22,466
- Exercise price
- $10.94
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Immediately exercisable.
Footnote F2
This option vested or shall vest in forty-eight (48) equal monthly installments commencing on March 22, 2021, subject to the Reporting Person's continuous service through each such vesting date.
Footnote F3
One fourth (1/4th) of the shares subject to the option award vested on January 20, 2023, and the remaining shares subject to the option vested or shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.
SEC remarks
Exhibit List - Exhibit 24 - Power of Attorney